Skip to content
GenoLensGenoLens

APRT

Chr 16q24.3

adenine phosphoribosyltransferase

MANE:
ENST00000378364.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Nephrocalcinosis or nephrolithiasis

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Unexplained kidney failure in young people

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

Disease associations (Open Targets)

  • adenine phosphoribosyltransferase deficiency

    0.81
  • neurodegenerative disease

    0.40
  • pathological myopia

    0.26
  • chronic kidney disease

    0.24
  • hereditary disease

    0.19
  • stage 5 chronic kidney disease

    0.19
  • interstitial nephritis

    0.19
  • nephronophthisis

    0.10
  • familial idiopathic steroid-resistant nephrotic syndrome

    0.10
  • focal segmental glomerulosclerosis

    0.09

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Adenine phosphoribosyltransferase

Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.